India Globalization Capital, Inc. engages in the development of cannabis-based therapies to treat Alzheimer's, pain, nausea, eating disorders, several end points of Parkinson's, and epilepsy in humans, dogs, and cats. The company's products under medical trials include Natrinol, a natural substitute for Marinol for relieving nausea, vomiting, and increasing appetite in patients with AIDS and cancer; Caesafin to alleviate seizures in dogs and cats; Serosapse addresses several end points in Parkinson's disease, including Rapid Eye Movement sleep disorder, anxiety, and dyskinesia; and Hyalolex to reduce the buildup of beta-amyloid in Alzheimer's patients. It also provides construction management services for the construction of a 7-star hotel in Genting Malaysia; and rents heavy equipment with operators to construction companies. India Globalization Capital, Inc. has a joint development and services agreement with The Parkinson's Institute and Clinical Center to develop cannabis related products for treating various end points of Parkinson's disease and movement disorders. The company was founded in 2005 and is based in Bethesda, Maryland.
Industry, Sector and Symbol
Stock Exchange NYSEAMERICAN
Industry Steel & Iron
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSEAMERICAN:IGC
CUSIPN/A
Phone+1-301-9830998
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-69.92%
Return on Equity-31.15%
Return on Assets-20.04%
Miscellaneous
EmployeesN/A
Outstanding Shares31,310,000
Market Cap$19.60
India Globalization Capital (NYSEAMERICAN:IGC) Frequently Asked Questions
What is India Globalization Capital's stock symbol?
India Globalization Capital trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "IGC."
How were India Globalization Capital's earnings last quarter?
India Globalization Capital, Inc. (NYSEAMERICAN:IGC) released its quarterly earnings data on Tuesday, February, 20th. The construction company reported ($0.02) EPS for the quarter. The construction company earned $0.76 million during the quarter. India Globalization Capital had a negative net margin of 69.92% and a negative return on equity of 31.15%. View India Globalization Capital's Earnings History.
When is India Globalization Capital's next earnings date?
What is the consensus analysts' recommendation for India Globalization Capital?
0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for India Globalization Capital in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."
Are investors shorting India Globalization Capital?
India Globalization Capital saw a decrease in short interest in June. As of June 15th, there was short interest totalling 397,423 shares, a decrease of 7.6% from the May 31st total of 429,922 shares. Based on an average trading volume of 208,660 shares, the days-to-cover ratio is presently 1.9 days. Currently, 1.5% of the company's shares are short sold. View India Globalization Capital's Current Options Chain.
Who are some of India Globalization Capital's key competitors?
Who are India Globalization Capital's key executives?
India Globalization Capital's management team includes the folowing people:
- Mr. Ram Mukunda, Exec. Chairman, Pres & CEO (Age 59)
- Ms. Claudia Grimaldi, VP & Principal Financial Officer (Age 47)
- Mr. Rohit Goel, Principal Accounting Officer (Age 24)
- Mr. Shajy Mathilakathu, Co-Principal Financial & Accounting Officer (Age 50)
- Dr. Jagadeesh Rao, Scientific Officer (Age 51)
Has India Globalization Capital been receiving favorable news coverage?
News articles about IGC stock have been trending somewhat positive recently, Accern Sentiment reports. The research firm rates the sentiment of media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. India Globalization Capital earned a media sentiment score of 0.07 on Accern's scale. They also assigned headlines about the construction company an impact score of 45.68 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.
How do I buy shares of India Globalization Capital?
Shares of IGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is India Globalization Capital's stock price today?
One share of IGC stock can currently be purchased for approximately $0.45.
How big of a company is India Globalization Capital?
India Globalization Capital has a market capitalization of $19.60 million.
How can I contact India Globalization Capital?
India Globalization Capital's mailing address is 4336 Montgomery Ave, BETHESDA, MD 20814-4443, United States. The construction company can be reached via phone at +1-301-9830998.
MarketBeat Community Rating for India Globalization Capital (NYSEAMERICAN IGC)
MarketBeat's community ratings are surveys of what our community members think about India Globalization Capital and other stocks. Vote "Outperform" if you believe IGC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IGC will underperform the S&P 500 over the long term. You may vote once every thirty days.
